Statins associate with better clinical outcomes in chronic hepatitis B patients with HBsAg seroclearance
ConclusionPatients with HBsAg seroclearance have favorable long-term survival. However, liver-related adverse outcomes still develop, necessitating further investigations on beneficial effects of statins.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Beta-Blockers | Cancer & Oncology | Carcinoma | Cholesterol | Cirrhosis | Diabetes | Endocrinology | Fortamet | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Infectious Diseases | Laboratory Medicine | Liver | Liver Cancer | Liver Transplant | Metformin | Statin Therapy | Transplants | Urology & Nephrology